alexa Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.


Journal of Multiple Sclerosis

Author(s): Trebst C, Bronzlik P, Kielstein JT, Schmidt BM, Stangel M, Trebst C, Bronzlik P, Kielstein JT, Schmidt BM, Stangel M

Abstract Share this page

Abstract BACKGROUND: Therapeutic plasma exchange (TPE) in steroid-unresponsive relapses of patients with multiple sclerosis (MS) is an established therapy with response rates of up to 70\%. Immunoadsorption (IA) specifically removes immunoglobulins from the patient's plasma. It is hypothesized that IA therapy might be better tolerated than and as effective as TPE in the treatment of MS relapses. Experiences with IA therapy of steroid-unresponsive MS relapses are limited. METHODS: We report our experiences with IA therapy in a series of 10 patients with steroid-unresponsive MS relapses. RESULTS: A marked to moderate clinical response with clear gain of function was observed in 66\% of our patients. IA therapy was well tolerated. CONCLUSIONS: IA therapy is an effective and well-tolerated therapeutic option for steroid-unresponsive MS relapses. Copyright © 2011 S. Karger AG, Basel. This article was published in Blood Purif and referenced in Journal of Multiple Sclerosis

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version